Neoadjuvant Ipilimumab in Prostate Cancer

NCT01194271 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Leuprolide Acetate
DRUG: Ipilimumab
PROCEDURE: Radical Prostatectomy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]